Understanding Receptor-Ligand Interactions as A Prerequisite for Virtual Screening

Virtual Screening for Bioactive Molecules

Volumn 10, Issue , 2008, Pages 207-227

  Klebe, Gerhard ^a   Grädler, Ulrich ^a   Grüneberg, Sven ^a   Krämer, Oliver ^a   Gohlke, Holger ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Chemical structure; High throughput screening; Libraries; Ligand binding; Virtual screening

Indexed keywords

LIBRARIES; LIGANDS; STRUCTURE (COMPOSITION); THROUGHPUT;

HIGH THROUGHPUT SCREENING; LIGAND BINDING; RECEPTOR-LIGAND INTERACTIONS; VIRTUAL SCREENING;

DIGITAL LIBRARIES;

EID: 84956809096     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527613083.ch10     Document Type: Chapter

References (54)

1. H. Kubinyi, Curr. Opin. Drug Discov. Develop. 1998, 1, 4-15.
2. K. Milller, in Perspectives in Drug Discovery and Design Vol. 3, P. S. Anderson, G. L. Kenyon, G. R. Marshall (Eds.), ESCOM, Leiden 1995.
3. J. H. Van Drie, M. S. Lajiness, DDT 1998,3,274-283.
4. W. P. Walters, M. T. Stahl, M. A. Murcko, DDT 1998,3,160-178.
5. M. Hendlich, 1999, unpublished results.
6. H.-J. Bohm, G. Klebe, Angew. Client. 1996,108,2750-2778.
7. G. Klebe, J. Mol. Biol. 1994,237,212-235.
8. I. J. Bruno, J. C. Cole, J. P. Lommerse, R. S. Rowland, R. Taylor, M. L. Verdonk, J. Comput.-Aided Mol. Des. 1997, 11, 525-537.
9. H. J. Bohm, J. Comput.-Aided Mol. Des. 1992,6, 61-78.
10. P. J. Goodford, J. Med. Chem. 1985,28, 849-857.
11. M. L. Verdonk, J. C. Cole, R. Taylor, J. Mol. Biol. 1999,289,1093-1108.
12. H. Gohlke, K. Hendlich, G. Klebe, Perspect. Drug Design Discov. 2000, in press
13. Database ACD (Available Chemicals Directory), MDL Information Systems, Inc., San Leandro, CA.
14. Program UNITY Chemical Information Software, v. 4.0.3, Tripos Associates Inc., St. Louis, MO.
15. T. Hurst, J. Chem. Inf. Comput. Sci. 1994,34,190-196.
16. S. K. Kearsley, G. M. Smith, Tetrahedron Comp. Methodol. 1990,3,615-633.
17. G. Klebe, T. Mietzner, F. Weber, J. Comput.-Aided Mol. Des. 1994,8,751-778.
18. G. Klebe, T. Mietzner, F. Weber, J. Comput.-Aided Mol. Des. 1999,13, 35-49.
19. O. Kramer, diploma thesis, Rationales Wirkstoff-Design am Beispiel der Aldose-Reduktase, Philipps-University of Marburg, 1999.
20. C. Lemmen, T. Lengauer, J. Comput.-Aided Mol. Des. 1997,11, 357-368.
21. G. Klebe, T. Mietzner, J. Comput.-Aided Mol. Des. 1994,8,583-606.
22. M. Rarey. B. Kramer, T. Lengauer, G. Klebe, J. Mol. Biol. 1996,261,470-489.
23. G. Jones, P. Willet, R. C. Glen, A. R. L. Leach, R. Taylor, J. Mol. Biol. 1997,267,727-748.
24. T. J. A. Ewing, I. D. Kuntz, J. Comput. Chem. 1997,9,1175-1189.
25. I. D. Kuntz, E. C. Meng, B. K. Shoichet, Ace. Chem. Res. 1994,27,117-123.
26. T. Lengauer, M. Rarey, Curr. Opin. Struct. Biol. 1996,6,402-406.
27. H.-J. Bohm, G. Klebe, Angew. Chem. Int. Ed. Engl. 1996,35,2566-2587.
28. D. L. Beveridge, F. M. DiCapua, Annu. Rev. Biophys. Biophys. Chem. 1989,18, 431-492.
29. P. Kollman, Chem. Rev. 1993, 93,2395-2417.
30. H.-J. Bohm, J. Comput.-Aided Mol. Des. 1994,8, 243-256.
31. H. J. Bohm, J. Comput.-Aided Mol. Des. 1998,12,309-323.
32. I. Muegge, Y. C. Martin, J. Med. Chem. 1999, 42,791-804.
33. J. B. O. Mitchell, R. A. Laskowski, A. Alex, J. M. Thornton, J. Comput. Chem. 1999,20,1165-1176.
34. H. Gohlke, K. Hendlich, G. Klebe, J. Mol. Biol. 2000,295,337-356.
35. M. Hendlich, Acta Crystallogr. D. 1998, 54, 1178-1182.
36. J. B. O. Mitchell, R. A. Laskowski, A. Alex, M. J. Forster, J. M. Thornton, J. Comput. Chem. 1999, 20,1177-1185.
37. N. Okada, S. Nishimura, J. Biol. Chem. 1979,254,3061-3066.
38. U. Gradler, R. Ficner, G. A. Garcia, M. T. Stubbs, G. Klebe, K. Reuter, FEBS Lett. 1999, 454, 142-146.
39. B. C. Persson, Mol. Microbiol. 1993,8,1011-1016.
40. J. M. Durand, N. Okada, T. Tobe, M. Watarai, I. Fukuda, T. Suzuki, N. Nakata, K. Komatsu, M. Yoshikawa, C. Sasakawa, J. Bacteriol. 1994,176, 4627-41634.
41. T. H. Maren, Drug Development Research 1987,10, 255-276.
42. G. M. Smith, R. S. Alexander, D. W. Christianson, B. M. McKeever, G. S. Ponticello, J. P. Springer, W. C. Randall, J. J. Baldwin, C. N. Habecker, Protein Sci. 1994,3,118-125.
43. L. R. Scolnick, A. M. Clements, J. Liao, L. Crenshaw, M. Hellberg, J. May, T. R. Dean, D. W. Christianson, J. Am. Chem. Soc. 1997,119, 850-851.
44. P. A. Boriack-Sjodin, S. Zeitlin, H. H. Chen, L. Crenshaw, S. Gross, A. Dantanarayana, P. Delgado, J. A. May, T. Dean, D. W. Christianson, Protein Sci. 1998, 7,2483-2489.
45. Database MAYBRIDGE, Maybridge Chemical Company Ltd., Tintagel, Cornwall, England.
46. M. F. Sugrue, A. Harris, I. Adamson, Drugs of Today 1997,33, 283-298.
47. J. I. Wallace, Clinical Diabetes 1999,17,19-26.
48. P. F. Kador, Med. Res. Rev. 1988,8,325-352.
49. A. Urzhumtsev, F. Tete-Favier, A. Mitschler, J. Barbanton, P. Barth, L. Urzhumtseva, J. F. Biellmann, A. Podjarny, D. Moras, Structure 1997,5, 601-612.
50. O. Kramer, G. Klebe, 1999, unpublished results.
51. R. D. Cramer, III, D. E. Patterson, J. D. Bunce, J. Am. Chem. Soc. 1988,110,5959-5967.
52. G. Klebe, U. Abraham, T. Mietzner, J. Med. Chem. 1994,37,4130-4146.
53. G. Klebe, U. Abraham, J. Comput.-Aided Mol. Design 1999,13,1-10.
54. D. A. Campbell, J. C. Bermate, T. S. Burkoth, D. V. Patel, J. Am. Chem. Soc. 1995,117,5372.